572650 Sigma-AldrichSU9516 - CAS 666837-93-0 - Calbiochem
A cell-permeable 3-substituted indolinone compound that displays anti-proliferative and proapoptotic properties in tumor cells.
More>> A cell-permeable 3-substituted indolinone compound that displays anti-proliferative and proapoptotic properties in tumor cells. Less<<Synonyms: 3-[1-(3H-Imidazol-4-yl)-meth-(Z)-ylidene]-5-methoxy-1,3-dihydro-indol-2-one
Recommended Products
Overview
| Replacement Information |
|---|
Key Spec Table
| CAS # | Empirical Formula |
|---|---|
| 666837-93-0 | C₁₃H₁₁N₃O₂ |
Pricing & Availability
| Catalogue Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
|---|---|---|---|---|---|---|
| 572650-5MGCN |
|
Plastic ampoule | 5 mg |
|
— |
| References | |
|---|---|
| References | Yu, B., et al. 2002. Biochem. Pharmacol. 64, 1091. Lane, M.E., et al. 2001. Cancer Res. 61, 6170. |
| Product Information | |
|---|---|
| CAS number | 666837-93-0 |
| ATP Competitive | Y |
| Form | Yellow to orange solid |
| Hill Formula | C₁₃H₁₁N₃O₂ |
| Chemical formula | C₁₃H₁₁N₃O₂ |
| Reversible | Y |
| Structure formula Image | |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | Cdk2/A |
| Primary Target IC<sub>50</sub> | 22 nM for Cdk2/A; 40 nM for Cdk1/B; 200 nM for Cdk4/D1 |
| Purity | ≥95% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | Y |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Catalogue Number | GTIN |
| 572650-5MGCN | 04055977266313 |
Documentation
SU9516 - CAS 666837-93-0 - Calbiochem SDS
| Title |
|---|
SU9516 - CAS 666837-93-0 - Calbiochem Certificates of Analysis
| Title | Lot Number |
|---|---|
| 572650 |
References
| Reference overview |
|---|
| Yu, B., et al. 2002. Biochem. Pharmacol. 64, 1091. Lane, M.E., et al. 2001. Cancer Res. 61, 6170. |



